Breaking News:Dangerous Delays: What Washington State (Re)Teaches Us About Cash and Cannabis Store Robberies [REPORT]

State Courts

RSS Feed for this category

Mississippi Becomes Latest State to Legalize Medical Marijuana [FEATURE]

With the signature of Gov. Tate Reeves (R) on a compromise medical marijuana bill on Wednesday, Mississippi becomes the 37th state to legalize the use of marijuana for medicinal purposes.

Mississippians should see dispensaries operating before year's end. (Sondra Yruel/Drug Policy Alliance)
Mississippi voters had overwhelmingly approved medical marijuana at the polls in November 2020, passing a broad medical marijuana measure, Initiative 65, with 74% of the vote (and rejecting a more restrictive legislative alternative, Initiative 65A.) But that victory was nullified by the state Supreme Court, which ruled that the state's signature gathering requirements for initiatives could not be complied with, invalidating not only Initiative 65 but also the whole initiative process in the state.

Heedful of the will of the people, both the legislature and the governor vowed to get a medical marijuana bill passed. The Supreme Court ruling was in May 2021; it took until now for the executive branch and the legislative branch to come to agreement on how to replace what the judicial branch threw out. Meanwhile, patients waited increasingly impatiently.

They got medical marijuana, but in a more restrictive form that what the voted for back in 2020. The Mississippi Medical Cannabis Act (Senate Bill 2095) allows patients to purchase smokeable marijuana, but only ¾ of an ounce per week, and there is no provision for home cultivation. Marijuana flower must be no more than 30 percent THC, while concentrates must be no more than 60 percent.

People with a specified list of conditions -- cancer, Parkinson's, Huntington's, muscular dystrophy, glaucoma, spastic quadriplegia, HIV, AIDS, hepatitis, amyotrophic lateral sclerosis (ALS), Crohn's, ulcerative colitis, sickle cell anemia, Alzheimer's, agitation of dementia, PTSD, autism, pain refractory to opioid management, diabetic/peripheral neuropathy, spinal cord disease, or severe injury -- qualify for medical marijuana.

People with chronic medical conditions that produce wasting, severe nausea, seizures, severe muscle spasms, and chronic pain also qualify, but chronic pain is narrowly defined as "a pain state in which the cause of the pain cannot be removed or otherwise treated, and which in the generally accepted course of medical practice, no relief or cure of the cause of the pain is possible, or none has been found after reasonable efforts by a practitioner."

Doctors, certified nurse practitioners, physician assistants, and optometrists can all sign recommendations for patients if they believe the patient "would likely receive medical or palliative benefit" from medical marijuana. But before they can do that, they have to have completed eight hours of continuing medical education courses on medical marijuana (and five hours each year after that) and have performed an in-person examination of the patient.

People who want to get in the medical marijuana business can obtain licenses if they pay nonrefundable application fees ranging from $1,500 for a 1,000-square foot canopy micro-cultivator license to $100,000 for the largest operators. There is no cap on the number of medical marijuana businesses. There will be a wholesale tax of 5 percent in addition to the state sales tax of 7 percent.

Marijuana reform advocates generally praised the passage of the bill, though with some reservations.

"With this victory, tens of thousands of Mississippians with debilitating health conditions will finally be able to safely and legally access something that can alleviate their pain and improve their quality of life. Mississippi now serves as the latest example that medical cannabis legalization is possible in any state in the country. We are hopeful that this move will add to the growing momentum towards cannabis policy reform in the South," said Toi Hutchinson, president and CEO of the Marijuana Policy Project (MPP) in a press release.

"Marijuana access is long overdue for Mississippi's patients," NORML's State Policies Manager Jax James said in a blog post. "The overwhelming majority of voters decided in favor of this policy change over a year ago, and for the past 14 months the will of the people has been denied."

But James also expressed disappointment in some of both what the bill does contain and what it does not.

"We remain concerned that lawmakers saw fit to add unnecessary taxes on cannabis products, that patients are prohibited from home-cultivating limited amounts of cannabis for their own personal use, and that those with chronic pain are restricted from accessing cannabis products until first using more dangerous and addictive substances like opioids," she said.

For MPP, though, the bottom line was that another state now allows patients access to medical marijuana.

"Despite tremendous support, Mississipians faced an uphill battle for a medical cannabis program. With this new law, justice has finally prevailed. Patients in Mississippi who are seriously ill will no longer be subject to arrest and criminal penalties for using medical cannabis and instead will be met with compassion. We applaud the legislature for working to restore the will of the voters in one of the most conservative states in the nation and Gov. Reeves for signing it into law," said Kevin Caldwell, MPP Southeast legislative manager.

The state Department of Health will begin issuing patient registry cards in 60 days, begin accepting applications from practitioners and begin licensing marijuana businesses other than dispensaries within 120 days, and licensing dispensaries within 150 days. The clock is ticking.

SAFE Banking Act Gets Another Chance in the House, Opioid Makers Settle with Native American Tribes, More... (2/2/22)

An Arizona judge upholds social equity provisions in the state's marijuana law, the SAFE Banking Act will get another House floor vote, and more.

Marijuana Policy

SAFE Banking Act Heading for Another House Floor Vote. The House Rules Committee has cleared the way for the Secure and Fair Enforcement (SAFE) Banking Act to get another chance at passage. The bill, which aims to provide protections for financial institutions doing business with state-legal marijuana businesses, had passed out of the House as part of a defense appropriations bill but was killed by Senate negotiators who favored a vote on marijuana legalization first. Last week, bill sponsor Rep. Ed Perlmutter (D-CO) offered it as an amendment to a large-scale tech and manufacturing research and innovation bill, and on Tuesday, the Rules Committee determined the proposal to be in order, meaning it will be taken up by the House as part of that larger bill.

Arizona Judge Upholds Rules for Social Equity Marijuana Licenses. Maricopa County Superior Court Judge Randall Warner on Tuesday threw out a lawsuit challenging the state's rules implementing a program aimed promoting social equity in the marijuana industry. The program is reserving 26 marijuana business licenses for "people from communities disproportionately impacted by the enforcement of previous marijuana laws." The lawsuit filed by the Greater Phoenix Urban League and a business argued that the rules lack a means to prevent license transfers and to ensure that profits remain in communities, but Judge Randall held that the rules satisfied the broad mandates under the state's voter-approved marijuana legalization law.

Medical Marijuana

Minnesota Patients Can Buy Buds Beginning in March. Patients registered in the state's Medical Cannabis Program will be eligible to buy dried cannabis flower for smoking from the state's medical cannabis dispensaries starting March 1. In preparation for the change, registered patients interested in smokable cannabis can make an appointment for a consultation with a medical cannabis dispensary pharmacist beginning Feb. 1 so they will be pre-approved to buy pre-packaged dried flower and pre-rolls once available. Consultations, which can be in-person or virtual, are required when a patient changes the type of medical cannabis they receive. Smokable cannabis may be available a few days before March 1, if the state's relevant administrative rules are finalized early. Patients should check with their medical cannabis dispensary for further details. The sale of smokable cannabis is limited to patients and caregivers who are 21 years or older and who are registered with the Medical Cannabis Program.

Opioids

Drug Distributors, Johnson & Johnson Settles with Native American Tribes Over Opioid Distribution. Three drug distributors -- McKesson, Cardinal Health, and AmerisourceBergen -- and drug manufacturer Johnson & Johnson have reached a $665 million settlement with Native American tribes regarding the flood of prescription opioids into Native communities. More than 400 tribes sued the companies for producing and shipping opioids to the tribes regardless of concerns about overdoses and other health issues. The companies maintain they followed federal law and did nothing wrong but agreed to the settlement anyway. The lawsuit is part of a broader push-back after an expansion of opioid prescribing in the late 1990s and early 200s that has seen numerous lawsuits against drug companies, as well as reductions in opioid prescribing, which has left some chronic pain patients in the lurch.

The Top Ten Domestic Drug Policy Stories of 2021 [FEATURE]

Whew! Another year to put in the rear view mirror, but not before we reflect on the year that was. It was a year of tragic overdose death numbers and groundbreaking responses; it was a year of advances on marijuana reform in the states but statemate in Congress; it was a year of psychedelic advance in the states and cities -- but not enough political will to reform policing, at least not federally.

As always, there was a lot going on in the realm of domestic drug policy, and here are ten of the year's most important stories. Check back next week for our Top Ten International Drug Policy Stories of 2021.

1. Fentanyl, Pandemic Drive Drug Overdose Deaths to Record High

The nation either neared or surpassed the one millionth drug overdose death since 1999 in 2021. Driven largely by two factors -- pandemic-related isolation and lack of access to treatment services, and the increasing presence of the highly potent opioid fentanyl in the unregulated drug supply -- overdose deaths hit an all-time high in the year ending in March 2021, with 96,779 overdose deaths reported.

That's an increase of nearly 30 percent over the previous 12-month period, according to a Centers for Disease Control and Prevention (CDC) report in October. And as if that were not bad enough, CDC reported in November provisional estimates that drug overdose deaths had topped 100,300 in the period from May 2020 to April 2021 -- the highest one-year overdose death toll ever.

As for that million overall dead figure, the CDC reported that through 2019 the toll had reached 841,000. We are now two years past that, and while that figure hasn't been officially recorded, just adding up the numbers makes it likely that we have already reached that horrific benchmark.

2. Nation's First Official Safe Injection Site Opens in New York City

The legality of safe injection sites -- where drug users can consume their substances in a clean, well-lit place under medical supervision -- remains unsettled under federal law, but officials in New York City decided they couldn't wait. In November, Mayor Bill de Blasio, who began calling for them in 2018, and the city Health Department announced that "the first publicly recognized Overdose Prevention Center [safe injection site] services in the nation have commenced."

The move was quickly lauded by editorials in leading newspapers such as the Los Angeles Times and the Washington Post, and by Christmas Eve, the city reported that 59 overdoses had already been reversed amid 2,000 visits to the facilities. Meanwhile, a safe injection site in Philadelphia whose opening was blocked in January by a federal appeals court after the Trump administration Justice Department moved against it, is awaiting a March filing by the Biden administration to see if it will take a more positive position allowing the facility to open.

Bills to allow safe injection sites were introduced in a number of states, including California, Massachusetts, New Mexico, Rhode Island, and Utah, although only the Rhode Island bill passed and was signed into law. Still, the opening of the New York City facilities is a historic harm reduction first for the United States, and a likely harbinger of more to come.

3. Marijuana Reform Progress in the States

Nearly half the population now lives in legal marijuana states after five states this year joined the 13 others that had previously done so, mostly at the ballot box. But the states that legalized it this year all did so via the legislative process. Those are Connecticut (Senate Bill 1201), New Jersey (Assembly Bill 21/Senate Bill 21 and Assembly Bill 897), New Mexico (House Bill 2), New York (Senate Bill S854A), and Virginia (House Bill 2312/Senate Bill 1406).

This movement comes as marijuana legalization continues to garner strong public support, with a November Gallup poll reporting "a new high" of 68 per cent report. There was other marijuana-friendly legislative action in the states as well: Louisiana decriminalized it, four states (Colorado, Delaware, New Mexico, Virginia) passed expungement laws, Alabama approved medical marijuana (although not in smokeable form), and 17 states approved medical marijuana expansion laws. Weed is on a roll.

4. Democrats Haven't Got Federal Marijuana Legalization Done, and It's Not Looking So Great for Next Year, Either

With Democrats in control of Congress after the November 2020 elections, hopes were high that this could be the year federal marijuana prohibition would be ended. The House had already passed a legalization bill at the end of the last Congress, Senate Majority Leader Charles Schumer (D-NY) was pushing for it, and even if President Biden opposed full legalization and would only go as far as supporting decriminalization, that was a bridge that could be crossed when we came to it.

Now, at the end of 2021, that bridge is still a ways down the road. The Marijuana Opportunity, Reinvestment and Expungement (MORE) Act (HR 3617), sponsored by House Judiciary Committee Chair Rep. Jerrold Nadler (D-NY), passed the House of Representatives a year ago. But that was a different Congress, meaning it has to pass the House again. In this Congress it's only passed the Judiciary Committee, in late September, and hasn't moved since. On the Senate side, Schumer and Sens. Cory Booker (D-NJ) and Ron Wyden (D-OR) rolled out an initial draft of their legalization bill, the Cannabis Administration and Opportunity Act in mid-July, but have yet to formally file legislation.

One big reason for the impasse is that Democrats are at odds among themselves, tussling over whether to hold out for full legalization replete with social equity measures, or to go for incremental measures in the meanwhile, such as banking access for state-legal cannabusinesses through the SAFE Banking Act (HR 1996). That bill passed the House and was inserted into the annual defense funding bill, only to be removed at the insistence of Senate leadership in the former camp, including Majority Leader Charles Schumer (D-NY).

The fight over how to approach marijuana reform federally has split not only the Democrats, but also the drug reform movement, with groups like the Drug Policy Alliance calling for not passing banking except as part of a full legalization bill, while NORML and the Marijuana Policy Project lobbied hard for the SAFE Act.

As the year came to an end, Reps. Earl Blumenauer (D-OR) and Barbara Lee (D-CA) told the Congressional Cannabis Caucus that Congress would take up marijuana reform in the spring. But with an election year looming, Congress evenly divided, and not even all Democratic senators sure votes on marijuana legalization, Congress looks more likely to be nibbling at the edges of federal pot prohibition rather than ending it -- or perhaps to do nothing. There are dozens of marijuana-related bills filed, from expungement to veterans' access to easing research barriers and more. In 2021, nibbling at the edges may be the best we can do.

Meanwhile, in November, a GOP legislator, Sourth Carolina Rep. Nancy Mace filed her own bill, the States Reform Act, which would legalize marijuana at the federal level. It would do so by removing marijuana from Schedule I of the Controlled Substances Act, leaving it up to the states to set their own marijuana policies. The bill would also set a three percent federal excise tax, and release and expunge the records of those convicted of federal marijuana offenses. Mace said her bill represented a compromise that could gain support from both Republicans and Democrats.

Last year's mass mobilization around George Floyd's death has yet to translate to new laws restraining police misbehavior. (CC)
5. Even in the Wake of George Floyd, Police Reform Can't Move in the Senate

Following the death of George Floyd while being arrested by Minneapolis police and the massive mobilizations it generated, the impetus grew to reexamine and reform police practices. The spirit of reform in response to the crisis took root in both houses and both parties, with Republican South Carolina Senator Tim Scott filing a tepid Just and Unifying Solutions to Invigorate Communities Everywhere (JUSTICE) Act last year. But that bill lacked key provisions demanded by Democrats, such as an end to qualified immunity for police officers in civil lawsuits, and it died at the end of the last session.

That spirit of reform was embodied in February, when the House passed the George Floyd Justice in Policing Act (HR 1280), sponsored by Rep. Karen Bass (D-CA). That bill would make it easier to convict a police officer for misconduct in a federal prosecution and limit qualified immunity as a defense against liability in a private civil action against an officer. It also restricts the use of no-knock warrants, chokeholds, and carotid holds and creates a National Police Misconduct Registry, among other provisions.

Senator Cory Booker (D-NJ) envisioned something similar in the Senate when in June he announced his framework for comprehensive police reform legislation. Like the House bill, it too reformed qualified immunity so that people could actually recover damages from police who violate their constitutional rights. It too would make it easier to federally prosecute police misconduct. And it too would create a National Police Misconduct Registry, as well as banning racial profiling and providing incentives for states to adopt policies banning no-knock warrants, chokeholds, and other airway-restrictive holds in their use-of-force policies.

Booker and Scott would become the point men in a month's long effort to craft a police reform bill with bipartisan support over the course of the summer. But by September, the negotiations had hit a dead end, with Booker telling reporters: "We weren't making progress -- any more meaningful progress on establishing really substantive reform to America's policing," he said. And with that, federal police reform was dead for the year.

One of the irresolvable issues was qualified immunity, on which Scott and the Republicans refused to budge. Instead, in a statement noting the end of negotiations, Scott claimed "Democrats said no because they could not let go of their push to defund our law enforcement" and then, with a complete unawareness of irony, complained about using "a partisan approach to score political points."

So far in the Congress, it has been justice delayed. Will it end up being justice denied? There is still a year left in the session, so stay tuned.

6. The Biden Administration's Partial Embrace of Harm Reduction

From the outset, the Biden administration is proving to be the friendliest ever toward harm reduction, even though it has yet to acknowledge one of the most effective harm reduction interventions: safe injection sites (or "supervised consumption sites" or "overdose prevention centers"). The first signal came in March, when the administration included nearly $4 billion for substance abuse disorder and mental health, including funding for harm reduction activities such as needle exchange services in the coronavirus relief bill. The bill allocated $30 million in community-based funding for local substance use disorder services like syringe services programs and other harm reduction interventions.

Then, on April 1, the administration gave us the first big hint of what its drug policy will look like as it released the congressionally-mandated Statement of Drug Policy Priorities for Year One. That document contains a heavy dose of drug prevention, treatment, and recovery, but also prioritizes "enhancing evidence-based harm reduction efforts." The same month, it allowed federal funds to be used to buy rapid fentanyl test strips.

After a quiet summer, Health and Human Services (HHS) Secretary Xavier Becerra made news in October when he announced the department's overdose prevention strategy and committed to more federal support for harm reduction measures, such as needle exchanges, increased access to naloxone, and test strips to check drugs for the presence of fentanyl. He even suggested the agency might be open to safe injection sites, but in a sign of the delicacy of the subject in this administration, HHS quickly walked back the comments: "HHS does not have a position on supervised consumption sites," the statement read. "The issue is a matter of ongoing litigation. The Secretary was simply stressing that HHS supports various forms of harm reduction for people who use drugs."

In November, the administration released model naloxone legislation. The administration on Wednesday released model legislation to help states improve access to naloxone treatment for opioid overdoses. The model bill encourages people to obtain naloxone, protects them from prosecution when administering it, requires health insurance to cover it, and provides increased access to it in schools and correctional facilities.

Also in November, that $30 million from the coronavirus relief bill got real when SAMHSA announced it had launched $30 million harm reduction grant funding opportunity to "help increase access to a range of community harm reduction services and support harm reduction service providers as they work to help prevent overdose deaths and reduce health risks often associated with drug use."

The Biden administration is clearly moving in the direction of harm reduction, but where it comes down on safe injection sites is still muddy. The Justice Department is preparing a brief in the case of Safehouse, a proposed Philadelphia safe injection site that was blocked from opening after the Trump administration Justice Department persuaded the 3rd US Circuit Court of appeals that it violated the Controlled Substance Act's "crack house" provision. That brief will be a key indicator of whether the administration is prepared to fully embrace harm reduction, but we are going to have to wait until next year to find out.

7. Oregon Leads the Way on Drug Decriminalization, Others Are Vying to Follow

With the November 2020 passage of Measure 110 with 59 percent of the vote, Oregon became the first state to decriminalize drug possession, and by year's end, the initial results were looking pretty good. Because the measure tapped into marijuana tax revenues to fund treatment and harm reduction services, those programs are getting a hefty $302 million in much needed funding over the next two years.

While the numbers are not in yet for this first year of decriminalization, there were roughly 9,000 drug arrests a year prior to passage of Measure 110, and thousands of Oregonians who would have been arrested for drug possession this year have instead faced only their choice of a $100 fine or a health assessment. It won't be 9,000 fewer drug arrests, though, because some felony drug possession arrests (possession of more than the specified personal use amounts) have been downgraded to still arrestable misdemeanors. Still, it will be thousands fewer people subjected to the tender mercies of the criminal justice system and all the negative consequences that brings.

In the wake of the Oregon vote, a number of other states saw decriminalization bills introduced -- Florida, Kansas, Maine, New York, Vermont, Virginia and Washington -- and so did Congress, when Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO in June filed the Drug Policy Reform Act (DPRA), whose most striking provision is drug decrim. DPRA is the first time decriminalization bill to be introduced in Congress.

Also on the decrim front this year, efforts are underway in Washington, DC and Washington state to put initiatives on the ballot next year. The public seems to be ready: A summer poll from Data for Progress and The Lab found that 71 percent of respondents said federal anti-drug policies aren't working and reform is needed and 59 percent supported decriminalizing drug possession. A slightly earlier ACLU/Drug Policy Alliance poll around the same time had even stronger results, with 83% saying the war on drugs had failed and 66% supporting decrim. Decriminalization is starting to look like an idea whose time has come.

8. Conservative State Supreme Courts Negate the Will of the Voters

The November 2020 elections resulted in a clean sweep for drug reform initiatives, with marijuana legalization being approved in four states and medical marijuana in two states. But in two cases, marijuana legalization in South Dakota and medical marijuana in Mississippi, Republican-dominated state Supreme Courts moved to effectively negate the will of the voters.

In South Dakota, Constitutional Amendment A won with 54 percent of the vote, but acting at the behest of South Dakota anti-marijuana Republican Governor Kristi Noem, a county sheriff and the head of the Highway Patrol sued to block the measure. They won in circuit court and won again when the state Supreme Court threw out Amendment A, ruling it unconstitutional because it violated a provision limiting constitutional amendments to one subject. Noem's victory may prove ephemeral, though: The activists behind Amendment A are already collecting signatures for a 2022 initiative, and the state legislature didn't even wait for the Supreme Court decision to decide it is ready to legalize marijuana in the next session.

In Mississippi, Initiative 65 won with 74 percent of the vote, but a Republican local official successfully challenged it, and in May, the Republican-dominated state Supreme Court threw it out -- managing to wipe out the state's initiative process as it did so. Under the state constitution, initiative campaigns are required to get one-fifth of signatures from each of five congressional districts, which seems straightforward enough. The only problem is that since congressional reapportionment after the 2000 census, the state only has four districts, making it impossible for any initiative to comply with the constitutional language.

The state has seen numerous initiatives since 2000, with none of them challenged. When faced with the conundrum, the Supreme Court could have found that constitutional language "unworkable and inoperable on its face," but instead pronounced itself bound to find Amendment 65 "insufficient" because it cannot meet the five-district requirement.

The legislature has been working to craft a medical marijuana bill, but Republican Governor Tate Reeves is not happy with the legislative language and has refused to call a special session on medical marijuana. Mississippians will have to wait for 2022.

9. House Votes to End Crack/Powder Cocaine Sentencing Disparity, But Senate Dallies

In September, in an effort to undo one the gravest examples of racially-biased drug war injustice, the House voted to end the federal sentencing disparity between crack and powder cocaine. HR 1693, the Eliminating a Quantifiably Unjust Application of the Law (EQUAL) Act of 2021, passed on a vote of 361-66, demonstrating bipartisan support, although all 66 "no" votes came from Republicans. Amidst racially-tinged and "tough on drugs" political posturing around crack use in the early 1980s, accompanied by significant media distortions and oversimplifications, Congress passed the Anti-Drug Abuse Act of 1986, cosponsored by then-Senator Joe Biden (D-DE) and signed into law by Ronald Reagan. Under that bill, people caught with as little as five grams of crack faced a five-year mandatory minimum sentence, while people would have to be caught with 500 grams of powder cocaine to garner the same sentence.

While race neutral on its face, the law was disproportionately wielded as a weapon against African-Americans. Although similarly small percentages of both Blacks and Whites used crack, and there were more White crack users than Black ones, Blacks were seven times more likely to be imprisoned for crack offenses than Whites between 1991 and 2016. Between 1991 and 1995, in the depths of the drug war, Blacks were 13 times more likely to be caught up in the criminal justice meat grinder over crack. And even last year, the US Sentencing Commission reported that Black people made up 77 percent of federal crack prosecutions.

After years of effort by an increasingly broad alliance of drug reform, racial justice, human rights, religious and civic groups, passage of the 2010 Fair Sentencing Act took a partial step toward reducing those disparities. The FSA increased the threshold quantity of crack cocaine that would trigger certain mandatory minimums -- instead of 100 times as much powder cocaine than crack cocaine needed, it changed to 18 times as much.

The 2018 FIRST STEP Act signed by President Trump allowed people convicted before the 2010 law was passed to seek resentencing. And now, finally, an end to the disparity is in sight. The Senate version of the bill is S. 79, introduced by Senator Cory Booker (D-NJ) and cosponsored by fellow Democrat Dick Durbin (IL) and GOP Senators Rand Paul (KY), Rob Portman (OH), and Thomas Tillis (NC). After the vote, they prodded their Senate fellows to get moving. But the Senate bill has yet to move after being filed 11 months ago.

10. Psychedelic Reform Movement Broadens in States and Cities

The movement to ease or undo laws criminalizing psychedelic substances continued to broaden and deepen in 2021. Detroit and Seattle joined Denver and Oakland in the ranks of major cities that have embraced psychedelic reform, with the Seattle city council approving a psychedelic decrim measure in October and Detroit voters approving a psychedelic decrim measure in November.

A number of smaller towns and cities went down the same path this year too, including Cambridge, Massachusetts in February, Grand Rapids, Michigan, in September (joining Ann Arbor), Easthampton, Massachusetts in October (joining Cambridge, Northampton, and Somerville), and Port Townsend, Washington, in December.

Psychedelic reform bills are now making their way to statehouses around the country, with bills showing up in eight states by March and a handful more by year's end. Most of them have died or are languishing in committee, and a much-watched California psychedelic decriminalization bill, Senate Bill 519, has been pushed to next year after passing the state Senate only to run into obstacles in the Assembly. Two of them passed, though: New Jersey S3256, which lessens the penalty for the possession of any amount of psilocybin from a third degree misdemeanor to a disorderly persons offense punishable by up to six months in jail and/or a $1,000 fine, became law in February. Then Texas House Bill 1802, which would expand research on therapeutic psychedelics, became law in June.

Meanwhile, building on Denver's pioneering psilocybin decriminalization in 2019, a national advocacy group, New Approach PAC, has filed therapeutic psychedelic and full psilocbyin legalization initiatives aimed at 2022. Oakland activists have announced a "Go Local" initiative under which people could legally purchase entheogenic substances from community-based local producers. The move aims to build on the city's current psychedelic decriminalization ordinance, passed in 2019.

Medical Marijuana Update

The medical marijuana front remains fairly quiet this week, but there's unhappy news for New Mexico patients, and more.

New Mexico

New Mexico Judge Rules Medical Marijuana Patients Can't Buy as Much Marijuana as Recreational Users. Second Judicial District Court Judge Benjamin Chavez ruled last Thursday that medical marijuana patients cannot purchase the same amount as non-patients when recreational-use sales begin. In so ruling, he rejected a claim from a medical marijuana patient that he should be able to buy as much marijuana as a non-patient consumer. "Petitioner has failed to establish that he, as well as qualified patients, qualified caregivers, and reciprocal patients, have a clear legal right to purchase an additional two-ounces of medical cannabis, tax free, at this time, under the Cannabis Regulation Act," Chavez wrote. Under the state's medical marijuana program, patients are allowed to purchase just over seven ounces in a 90-day period. The state Medical Cannabis Program has proposed upping that limit to 15 ounces.

Ohio

Ohio Senate Approves Medical Marijuana Expansion. The state Senate on Wednesday approved a bill that would allow more dispensaries to sell medical marijuana, growers to grow more of it, and more patients to qualify for it by expanding the list of qualifying conditions to include any conditions for which a patients might "reasonably be expected" to find benefit or relief. The bill would also shift regulation of dispensaries from the pharmacy board to a new Division of Marijuana Control in the Commerce Department. The bill now heads to the House.

CO Psychedelic Initiatives Filed, San Francisco State of Emergency Over Drugs & Crime in Tenderloin, More... (12/20/21)

Joe Manchin thinks his constituents would use child tax credit payments to buy drugs, a state of emergency in San Francisco could clear the way for a safe injection site, and more.

Sen. Joe Manchin (D-WV) apparently doesn't think too highly of his constituents. (senate.gov)
Marijuana Policy

Congress Will Take Up Marijuana Reform in the Spring. In a memo to the Congressional Cannabis Caucus last Thursday, Reps. Earl Blumenauer (D-OR) and Barbara Lee (D-CA) wrote that so-far stalled marijuana reform legislation would be taken up in the spring. "The growing bipartisan momentum for cannabis reform shows that Congress is primed for progress in 2022, and we are closer than ever to bringing our cannabis policies and laws in line with the American people," they said. There are dozens of marijuana-related bills before Congress, ranging from full-out legalization to bills seeking to ease access to financial services for state-legal marijuana enterprises, as well as narrower bills dealing with topics such as legal marijuana sales in Washington, DC, and opening up opportunities for research on PTSD, among others.

Medical Marijuana

New Mexico Judge Rules Medical Marijuana Patients Can't Buy as Much Marijuana as Recreational Users. Second Judicial District Court Judge Benjamin Chavez ruled last Thursday that medical marijuana patients cannot purchase the same amount as non-patients when recreational-use sales begin. In so ruling, he rejected a claim from a medical marijuana patient that he should be able to buy as much marijuana as a non-patient consumer. "Petitioner has failed to establish that he, as well as qualified patients, qualified caregivers, and reciprocal patients, have a clear legal right to purchase an additional two-ounces of medical cannabis, tax free, at this time, under the Cannabis Regulation Act," Chavez wrote. Under the state's medical marijuana program, patients are allowed to purchase just over seven ounces in a 90-day period. The state Medical Cannabis Program has proposed upping that limit to 15 ounces.

Psychedelics

Colorado Activists File Psychedelic Therapeutic and Full Psilocybin Legalization Initiatives. A national advocacy group, New Approach PAC, has filed two separate psychedelic reform initiatives -- both with the same title, the Natural Medicine Healing Act -- one of which would legalize the possession and personal cultivation of psilocybin mushrooms and the other which would create a system of licensed businesses to produce natural entheogens for therapeutic use at "healing centers." The campaign builds on psilocybin decriminalization in Denver in 2019, the first such move in the country. Meanwhile, Oregon voters approved therapeutic psilocybin last year.

Drug Policy

Joe Manchin Privately Told Colleagues Parents Use Child Tax Credit Money on Drugs. Among Sen. Joe Manchin's (D-WV) reasons for announcing he would not support President Biden's Build Back Better bill was one that he didn't say out loud: That "he thought parents would waste monthly child tax credit payments on drugs instead of providing for their own children," the Huffington Post has reported, citing "two sources familiar with the senator's comments." The child tax credit has provided families with $300 a month per child, cutting childhood poverty rates nearly in half. The Post reported that "Manchin's comments shocked several senators," but are in line with other reported comments that he thought people would use proposed sick leave to go hunting. It also echoes long-standing conservative talking points about welfare.

Law Enforcement

San Francisco Mayor Declares State of Emergency in the Tenderloin. Mayor London Breed (D) declared a state of emergency in the city's Tenderloin district last Friday aimed at combatting rising crime, drug use, and homelessness there. The declaration allows city officials to suspend zoning laws to create a site that would offer shelter and mental health services to people suffering from drug addiction. Fully one quarter of all overdose deaths in the city last year took place in the Tenderloin. The move comes after the city Board of Supervisors approved the purchase of a building in the Tenderloin to house a proposed safe injection site. The declaration also takes aim at crime in the neighborhood. "We are in a crisis and we need to respond accordingly," Breed said. "Too many people are dying in this city, too many people are sprawled on our streets."

Medical Marijuana Update

Minnesota patients will soon be enjoying edibles, a Rhode Island lawsuit aimed at protecting patients from employment discrimination gets settled, and more.

Florida

Florida Bill to Protect Patient Privacy Filed. A bill to protect patient privacy by blocking the scheduled repeal of an exemption for medical marijuana from some public records requirements was filed Thursday. HB 7005 was filed by the House Government Operations Subcommittee. A companion bill is pending in the Senate.

Minnesota

Minnesota Medical Marijuana Program to Add Edibles as New Option. The state Health Department announced Wednesday that its medical marijuana program is adding edibles as a new option for patients. The department said it is adding infused edibles in gummies and chews as approved delivery methods for marijuana. Other approved delivery methods are pills, vapor oil, liquids, topicals, powdered mixtures, and orally dissolvable products, like lozenges, but not smokeable flowers. Smokeable flowers will be allowed in March 2022, based on a law approved by the legislature this year.

Rhode Island

Rhode Island ACLU Announces Settlement of Lawsuit Protecting Medical Marijuana Patients from Discrimination.The ACLU of Rhode Island on Thursday announced the settlement of a lawsuit dealing with the rights of medical marijuana patients in employment. The settlement comes four years after Rhode Island Superior Court Justice Richard Licht ruled in the case that a Westerly fabrics company discriminated against Christine Callaghan when consideration of a paid internship was rescinded because of her participation in the state's medical marijuana program and her acknowledgment that she therefore would not be able to pass a required pre-employment drug screen.

In its decision, the court held that the state's medical marijuana law, which bars discrimination in employment against cardholders, applies to job applicants like Callaghan. Under the settlement agreement, the company has agreed to pay Callaghan $3,500 in back pay and compensatory damages, and to pay attorneys' fees. The company has also agreed to amend its drug use policy to consider applicants who are authorized medical marijuana cardholders.

First Actual Fentanyl-Laced Marijuana Case -- Or Not? -- ICC Temporarily Suspends Philippines Probe, More... (11/22/21)

An Illinois judge rules the odor of raw marijuana is no longer a basis for a vehicle search, an Ohio move to legalize marijuana is nearing its signature-gathering goal, and more.

Philippine President Rodrigo Duterte, orchestrator of tens of thousands of drug war murders
Marijuana Policy

Connecticut Health Officials Confirm First Actual Case of Marijuana Laced with Fentanyl. While scattered police departments have previously reported cases of marijuana laced with the powerful opioid fentanyl, those claims have never panned out. But now, top Connecticut health officials say it has turned up there. After nearly 40 cases of reviving apparent overdose victims with the opioid overdose reversal drug naloxone who reported using only marijuana since July, the state Department of Public Health announced last Thursday that it had found fentanyl in a marijuana sample it tested. "This is the lab-confirmed case of marijuana with fentanyl in Connecticut and possibly the first confirmed case in the United States," said DPH Commissioner Manisha Juthani, MD.

Is it what it seems? Harm reductionionists have posited on email lists that it is likely to be a case of surface contamination, and noted that fentanyl requires a vaporize at different temperatures.

Illinois Judge Rules Smell of Marijuana No Longer Provides Basis for Vehicle Search. A district court judge in Whiteside County has ruled that the odor of raw marijuana alone does not provide probable cause for a warrantless search of a vehicle. Possession of up to an ounce of marijuana has not been a criminal offense since June 2019, but police officers continued to use the smell of weed as a reason to search vehicle during traffic stops. But Judge Daniel P. Dalton ruled that "there are a number of wholly innocent reasons a person or the vehicle in which they are in may smell of raw cannabis." Judge Dalton ruled that "the court finds the odor of raw cannabis alone is insufficient to establish probable cause." This is only a district court opinion, and the state can appeal if it chooses.

Ohio Marijuana Legalization Petition Nearing Enough Signatures to Force Legislature to Act. The state Coalition to Regulate Marijuana Like Alcohol, which is pushing a signature-gathering campaign for an initiated statute that would force lawmakers to act on legalization or send the issue to a popular vote, says it is nearing the required 133,000 valid voter signatures to force the issue. If they reach that signature goal, the General Assembly would have four months to act on the proposal. If lawmakers fail to act or reject legalization, petitioners would then have to gather more signatures to send the issue to the voters in the next general election. The proposal would legalize the possession of up to 2.5 ounces of marijuana, set up a system of retail sales, and allow people to grow up to two plants of their own.

International

International Criminal Court Temporarily Suspends Probe into Human Rights Violations in Philippines Drug War. The chief prosecutor of the International Criminal Court (ICC) has temporarily suspended a formal investigation into human rights abuses during outgoing Philippine President Rodrigo Duterte's bloody war on drugs and drug users. The move comes after the Philippines government filed a request for deferral, saying its own investigations into drug war killings were underway.

"The prosecution has temporarily suspended its investigative activities while it assesses the scope and effect of the deferral request," ICC chief prosecutor Karim Khan wrote. Khan wrote that he would seek more information from the Philippines. Duterte pulled the Philippines out of the ICC in 2018 and had vowed that it would not cooperate with the ICC, but has allowed severely limited investigations into several dozen killings out of the thousands admitted by the government and the more than 30,000 claimed by human rights groups.

Those groups called on the ICC to get back to investigating Duterte: "We ask the ICC not to allow itself to be swayed by the claims now being made by the Duterte administration," said the National Union of People's Lawyers, which represents some victims' families. The national justice system is "extremely slow and unavailing to the majority of poor and unrepresented victims", the statement said. The Duterte government's claim that existing legal mechanisms could bring justice to Duterte's victims was "absurd," said Human Rights Watch. "Let's hope the ICC sees through the ruse that it is," said Brad Adam, HRW Asia director.

CO Announces Stricter MedMJ Rules, German Coalition Nearing Marijuana Legalization Deal, More... (11/12/21)

A New Jersey judge's ruling keeps an Atlantic City needle exchange program alive (for now), the Scottish government is trying to find a way to open a safe injection site in Glasgow, and more.

Medical Marijuana

Colorado tightens its medical marijuana rules, mainly around concerns about youth, dabs, and wax. (Creative Commons)
Colorado Announces New, Stricter Medical Marijuana Rules. As of January 1, the rules for purchasing medical marijuana will be tightened. Among the changes: daily purchases of marijuana flower will be limited to two ounces and eight grams of concentrates, such as wax or shatter. For patient between ages 18 and 20, the limit will drop to two grams per day. The current purchase limit for concentrates is 40 grams per day. To enforce the daily limits, dispensaries will be required to input patient ID numbers on patients' medical marijuana cards. The rule changes come after the legislature passed a bill largely driven about concerns about young people using high-potency marijuana concentrates.

Harm Reduction

New Jersey Judge Rules to Keep Atlantic City Needle Exchange Open -- At Least for Now. Judge Michael Blee of the Atlantic County Superior Court on Friday continued the restraints against Atlantic City enforcement of Ordinance 32 (which would terminate the city's syringe access services operated by South Jersey AIDS Alliance) until further order of the court. Judge Blee also ordered Atlantic City to provide the New Jersey Commissioner of Health with formal written notice of the adoption of Ordinance 32, together with pertinent documents from the litigation. He intends to issue a written opinion on the duration of the restraints no later than December 3.

"Syringe access is health care, period. Every day that the clients of South Jersey AIDS Alliance have access to lifesaving health care service is a day worth celebrating, and we're thrilled that our syringe services will continue operation for the time-being," said Carol Harney, Chief Executive Officer of South Jersey AIDS Alliance. "Our job is to show up for people living with HIV and living with a substance use disorder with the best public health tools we have, and there is no denying that syringe access is an essential service for Atlantic City residents."

International

Germany's Next Coalition Nears Deal on Legalizing Marijuana. The parties likely to form the next governing coalition -- the Social Democrats, the Greens, and the Free Democrats -- are close to a deal on legalizing marijuana. The parties are hammering out details, including rules for the use and sale of marijuana. But it's not a done deal yet, and the outcome could still change. Spokespeople for the three parties declined to comment on the negotiations. The effort comes as public support for marijuana legalization has hit 49 percent with 46 percent opposed -- the first time those in favor polled higher than those opposed.

Scottish Government Working on New Plan for Safe Injection Site in Glasgow. The Scottish government is "actively exploring" ways to open a safe injection site in Glasgow, Deputy Prime Minister John Swinney said Thursday. There are legal and political barriers to overcome. The comment comes after the current Lord Advocate said last week that even though a previous Lord Advocate had ruled in 2017 that such facilities violated the Misuse of Drugs Act, the issue "could be looked at again." But the notion still faces opposition from British Prime Minister Boris Johnson, and it is the British government that determines drug policy for the union. Some 1,339 people died of drug overdoses last year in Scotland, the seventh year in a row of rising overdose deaths.

OK Supreme Court Throws Out $465 Million J&J Opioid Settlement, Detroit Dope Squad Probe Ends More... (11/10/21)

Civil rights groups ask for expanded clemency options for federal prisones sent home during the pandemic emergency, an Ohio bill would greatly expand the state's medical marijuana program, and more.

Medical Marijuana

OH Bill Would Allow Medical Marijuana for Any Patient Who Can "Reasonably Be Expected to Benefit" from It. State Sen. Stephen Huffman (R) has filed a bill that would expand qualifying conditions for medical marijuana use to include arthritis, migraines, autism spectrum disorder, spasticity or chronic muscle spasms, hospice care, opioid use disorder, and the open-ended any condition from which a patient could benefit or obtain relief. The measure is Senate Bill 261, and it would also allow curbside pickup and drive-through dispensing, as has been allowed during the coronavirus epidemic. But wait, there's more: The bill would also expand the number of dispensaries to one for every thousand registered patients, up to the first 300,000 patients. After that, additional dispensaries would be added on an as-needed basis. The bill would also triple the maximum size of medical marijuana cultivation sites from 25,000 square feet to 75,000 square feet for large growers and allow small-scale growers to grow up to 20,000 square feet, up from the current 3,000. Huffman said he expects his bill to be sent to the Senate Small Business and Economic Opportunity Committee, with a hearing next week.

Opioids

Oklahoma Supreme Court Throws Out $465 Million Opioid Ruling Against Johnson & Johnson. In a setback for those seeking to hold pharmaceutical manufactures accountable for their role in the opioid crisis, the state Supreme Court on Tuesday overturned a 2019 lower court ruling that found Johnson & Johnson liable and ordered it to pay $465 million. That is the second time this month that a court has reversed decisions requiring drug companies to pay for their role in the opioid crisis. A California judge ruled similarly on November 1. In Tuesday's case, the high court rejected the state's contention that the company violated "public nuisance laws," and the two decisions together invalidate a key legal strategy used by plaintiffs in thousands of cases attempting to hold the drug companies responsible. But "public nuisance" laws vary from state to state, so it is not clear how much impact these decisions will have in other states. The state had argued that J & J created a "public nuisance" by aggressively overstating the benefits and downplaying the dangers of their prescription opioids.

Law Enforcement

Detroit Police Conclude Two-Year Probe into Crooked Dope Squad. Detroit Police Chief James White said Tuesday that a two-year internal affairs probe into corruption in the departments drug unit known as the Operation Clean Sweep Taskforce has ended and "we're confident we rooted out the problem." The probe found numerous examples of misconduct, including overtime fraud, forgery, false affidavits, and perjury, leading 12 members of the Narcotics Squad to leave the department under investigation. The Wayne County Prosecutor's Office is still evaluating whether to bring criminal charges against any squad members.

Sentencing

Civil Rights Groups Ask White House to Expand Pandemic Clemency. Some 29 civil rights and civil liberties groups have coalesced to ask the White House to broaden a plan to grant clemency to inmates released to home confinement during the coronavirus pandemic. They say the current policy wrongfully excludes people convicted of non-drug-related crimes and people serving long sentences. Some 4,800 federal prisoners were released early because of the pandemic but face a return to prison once the emergency ends if no clemency is granted. The attorney general is on board: "It would be a terrible policy to return these people to prison," Merrick Garland told lawmakers last month, but his Justice Department says it lacks the legal authority to let the prisoners stay at home. The Biden administration is only allowing released inmates to seek clemency if they are low-level non-violent drug offenders with less than four years to serve.

Opioid Makers Win One in California Court, NH Marijuana Legalization Bill Filed, More... (11/2/21)

The DC council retreats from language that would have threatened a crackdown on the city's marijuana "gift economy," a California court rules in favor of opioid manufacturers in a rare victory for the industry, and more.

Marijuana Policy

JAMA Study Finds Legalizing or Decriminalizing Marijuana Reduces Race-Based Arrests. A study published in the Journal of the American Medical Association (JAMA) finds that states that legalize or decriminalize marijuana see "large reductions in race-based arrests among adults" while those states that do not continue to see "increases in arrest rate disparities." Legalization was associated with 561 fewer arrests per 100,000 Black people and 185 fewer arrests per 100,000 White people, while decriminalization was associated with 449 fewer arrests per 100,000 Black people and 117 for White people. On the other hand, "cannabis arrests for adults and youth increased over time in states that did not implement a cannabis policy change," the study concluded. "Overall, results revealed that states that implemented a cannabis policy change saw large decreases in arrests compared with states that had no policy reform," the researchers concluded.

New Hampshire Marijuana Legalization Bill Filed. State Rep. Tim Egan (D-Grafton) has filed a bill that would legalize the possession of up to an ounce of pot and allow for home grows of up to three mature plants. The bill also envisions a system of taxed and licensed marijuana production and sales. While the House passed a similar bill last year, legalization efforts in the state face an obstacle in Gov. Chris Sununu (R), who has historically opposed legalization.

DC Council Removes Marijuana Bill Language That Threatened Crackdown on Unregulated Market. A provision of a DC marijuana bill that could have led to a crackdown on the city's unregulated marijuana "gift economy," which skirts the ban on legal retail sales, was removed Monday as the council prepares to vote on the measure on Tuesday. The move came after strong criticism from activists, who argued that targeting those currently providing marijuana would perpetuate systemic racial inequalities that marijuana legalization is supposed to reduce. There are currently estimated to be dozens of grey market pot shops and more than a hundred delivery services operating in the city.

Opioids

California Judge Rules for Drug Makers in Lawsuit Over Opioid Crisis. A California state judge has handed a rare victory to opioid manufacturers by rejecting the legal argument successfully employed against the industry in thousands of cases charging that it substantially contributed to an opioid epidemic that has taken more than half a million lives since the late 1990s, when the appearance of OxyContin marked the beginning of the current wave. "There is simply no evidence to show that the rise in prescriptions was not the result of the medically appropriate provision of pain medications to patients in need," wrote Judge Peter Wilson of Orange County State Superior Court. The counties of Santa Clara, Los Angeles, and Orange and the city of Oakland had sued four opioid manufacturers—Johnson & Johnson, Teva, Allergan, and Endo Pharmaceuticals—charging that their manufacturing and distribution of opioids constituted a "public nuisance, but Judge Wilson held that even if the companies were found to have created false or misleading marketing, "any adverse downstream consequences flowing from medically appropriate prescriptions cannot constitute an actionable public nuisance."

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, 2017 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, Vaping, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Pill Testing, Safer Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psilocybin / Magic Mushrooms, Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School